Skip to content

Physiotherapeutic intervention in patients with sequels of COVID-19

Physiotherapeutic Intervention in individuals with Post-COVID-19 Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9wrfxcn
Enrollment
Unknown
Registered
2023-03-08
Start date
2023-01-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2

Interventions

This is a three-arm, double-blind, randomized controlled clinical trial. The target sample will be 43 individuals with post-COVID-19 syndrome. Experimental group 1: 14 individuals with post-COVID-19 s
Phase 2: walking on a treadmill for 10 to 20 minutes
Phase 3: resistance exercises on gym machines for upper and lower limbs and trunk
Phase 4: balance exercises, such as mini squats and ankle flexions, free on the ground that will progress to destabilizing platforms, such as balance pad and disc-shaped balance pad
Phase 5: slow and sustained muscle stretching for 30 to 60 seconds of the main muscles of the upper and lower limbs and trunk), each session lasting between 40 and 60 minutes
two weekly sessions will be held for eight weeks, totaling 16 sessions. Experimental group 2: 15 individuals with post-COVID-19 syndrome will receive intervention through the Pilates Method in the sol
Phase 2: MatWork/MatPilates, which consists of 18 exercises performed in the ground modality aimed at the upper and lower limbs and trunk
Phase 3: Reformer, which consists of 06 exercises performed on this device aimed at upper and lower limbs and trunk
Phase 4: Chair, which consists of 06 exercises performed on this device aimed
E02.779
G11.427.410.698.277
E02.779.474

Sponsors

Universidade de Passo Fundo
Lead Sponsor
Universidade de Passo Fundo
Collaborator

Eligibility

Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Volunteers referred to the University of Passo Fundo Physiotherapy Service; age between 20 and 80 years; both genders; presence of symptoms related to SARS-CoV-2 infection and persistent for 12 weeks after diagnosis of COVID-19

Exclusion criteria

Exclusion criteria: Volunteers who complete less than 80% of the sessions; unable to walk (restricted to bed or wheelchair); gestational period; diagnosis of visual impairment, severe hearing impairment, cognitive decline (screened by the Mini Mental State Examination), pressure injuries, cancer, deep vein thrombosis, pulmonary thromboembolism, acute stroke, chronic obstructive pulmonary disease, cystic fibrosis, asthma, hypertension pulmonary; undergoing out-of-hospital physical rehabilitation in the last three months

Design outcomes

Primary

MeasureTime frame
It is expected to find an improvement in parameters related to physical health, which are pain, spinal flexibility, rib cage expansion, peripheral muscle strength, ventilatory muscle strength, lung capacity and volumes, functional capacity and physical conditioning, verified by through eight evaluation protocols, namely, the visual analogue scale, the spinal flexibility tests, the thoracic cirtometry, the manual dynamometry, the manovacuometry, the microspirometry, the sitting and standing test from a chair and the walking test of six minutes, respectively, from the verification of a variation of at least 5% in the pre- and post-intervention measurements.

Secondary

MeasureTime frame
It is expected to find an improvement in the parameters related to mental health, which are self-perception of health, quality of life, quality of sleep and symptoms of depression, anxiety and stress, verified through three evaluation protocols, namely, the Medical Outcomes Study 36 – Item Short-Form Health Survey, the Pittsburgh Sleep Quality Index and the Depression Anxiety Stress Scales-21, respectively, based on the verification of a variation of at least 5% in the pre- and post-intervention measurements.

Countries

Brazil

Contacts

Public ContactMatheus Jorge

Universidade de Passo Fundo

matheusjorge@upf.br+55 54 99971-1307

Outcome results

None listed

Source: REBEC (via WHO ICTRP)